AUSTRALIA
info@sudapharma.com
Facebook
Twitter
Linkedin
YouTube
+61 8 6142 5555
Menu
About Us
Snapshot
Our People
Leadership Team
Management Team
Scientific Advisory Board Members
Corporate Governance and Charters
Technology
Products
Zolpimist™ – Treatment for Insomnia
R&D
Anagrelide: Treatment for Cancer
Sumatriptan: Treatment for Migraine
Cannabinoids (CBD)
Ondansetron : Nausea
Sildenafil : Erectile Dysfunction/PAH
Midazolam: Treatment for Epilepsy & Anxiety
Investors
ASX Announcements
Presentations
Analyst Reports
Media
Contact Us
Annual Reports
30 June 2018
30 June 2017
30 June 2016
Recent Agreements
Latest SUDA Investor Presentation>>
ASX Announcements
27 Apr 21
Quarterly Appendix 4C and Activities Report
07 Apr 21
Anagrelide Project Update
30 Mar 21
Investor Presentation March 2021
29 Mar 21
Newsletter March 2021
29 Mar 21
Anagrelide Project Update
